Cover Image
市场调查报告书

全球HIV/AIDS诊断市场预测:各国检查数量、销售额预测、供应商市场占有率

HIV/AIDS Diagnostic Testing Market 2021: Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

出版商 Venture Planning Group 商品编码 238202
出版日期 内容信息 英文 292 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
全球HIV/AIDS诊断市场预测:各国检查数量、销售额预测、供应商市场占有率 HIV/AIDS Diagnostic Testing Market 2021: Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
出版日期: 内容信息: 英文 292 Pages
简介

本报告提供全球主要国家(美国、英国、德国、法国、义大利、西班牙、日本)的HIV/AIDS诊断相关市场相关分析,最新的研究开发、产品趋势和未来发展预测,今后5~10年的各国各部门(医院、开业医生、保健所、血液银行、门诊病人诊疗中心等)市场趋势--市场规模(检查数量),销售额,市场占有率等--,今后的市场发展策略和障碍,各企业简介等信息汇整,为您概述为以下内容。

第1章 简介

第2章 全球市场、技术概要

  • 背景情况
  • 诊断检验:HIV-1/2,HIV Ag,NAT,wesutanburotto
  • 疫苗及药物
  • 诊断设备的检讨和市场需求
  • 新的诊断技术

第3章 法国市场:市场规模,成长率,主要业者的销售额与市场占有率

第4章 德国市场:市场规模,成长率,主要业者的销售额与市场占有率

第5章 义大利市场:市场规模,成长率,主要业者的销售额与市场占有率

第6章 日本市场:市场规模,成长率,主要业者的销售额与市场占有率

第7章 西班牙市场:市场规模,成长率,主要业者的销售额与市场占有率

第8章 英国市场:市场规模,成长率,主要业者的销售额与市场占有率

第9章 美国市场:市场规模,成长率,主要业者的销售额与市场占有率

第10章 替代性的市场普及策略

  • 内部开发
  • 合资企业协定
  • 与大学的契约
  • 分散检验市场流通策略
    • 行销的方法
    • 产品的复杂性
    • 客户的偏好
    • 既有厂商
    • 新加入厂商
    • 主要种类的流通业者
    • 市场分类

第11章 加入市场的潜在障碍与风险

  • 市场的成熟度
  • 成本控制
  • 竞争
  • 最尖端的技术和那个限制
  • 专利保护
  • 法规的限制
  • 分散检验市场课题

第12章 竞争企业分析

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 荣研化学
  • Enzo Biochem
  • FUJIREBIO
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technologies
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • TaKaRa BIO
  • Thermo Fisher
  • Wallac
  • 和光纯药

图表一览

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: VPID28058

The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:

- Hospitals - Public Health Labs - Commercial/Private Labs
- Blood Banks - Physician Offices - Ambulatory Care Centers

For each country, in addition to the test volume and sales projections, the report presents the sales and market share estimates for major suppliers of AIDS tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies profiles leading suppliers and recent market entrants developing innovative technologies and products and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 292 pages and 36 tables

Table of Contents

I. Introduction

II. Worldwide Test Overview, Technologies and Instrumentation

  • A. Background, Diagnostic Tests, Vaccines and Drugs
  • B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Infectious Disease Automated and Semi-automated Analyzers
  • C. Emerging Infectious Disease Diagnostic Technologies
    • 1. Molecular Diagnostics
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Others
  • D. Personal Testing

III. Country Analyses: Sales and Volume Forecasts

IV. Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/Panels
  • C. Information Technology
  • D. Auxiliary Products

V. Design Criteria for Decentralized Testing Products

VI. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets

VII. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VIII. Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix/Erba
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech/Leica
  • Lonza
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher/Life Technology
  • Wallac/PE
  • Wako
Back to Top